Your browser doesn't support javascript.
loading
ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
Glajzer, Jacek; Castillo-Tong, Dan Cacsire; Richter, Rolf; Vergote, Ignace; Kulbe, Hagen; Vanderstichele, Adriaan; Ruscito, Ilary; Trillsch, Fabian; Mustea, Alexander; Kreuzinger, Caroline; Gourley, Charlie; Gabra, Hani; Taube, Eliane T; Dorigo, Oliver; Horst, David; Keunecke, Carlotta; Baum, Joanna; Angelotti, Timothy; Sehouli, Jalid; Braicu, Elena Ioana.
Afiliación
  • Glajzer J; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany. jacek.glajzer@gmail.com.
  • Castillo-Tong DC; Tumorbank Ovarian Cancer Network, Berlin, Germany. jacek.glajzer@gmail.com.
  • Richter R; Department of Oral and Cranio-Maxillofacial Surgery, University Hospital Erlangen, Erlangen, Germany. jacek.glajzer@gmail.com.
  • Vergote I; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Kulbe H; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • Vanderstichele A; Tumorbank Ovarian Cancer Network, Berlin, Germany.
  • Ruscito I; Division of Gynecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Trillsch F; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • Mustea A; Tumorbank Ovarian Cancer Network, Berlin, Germany.
  • Kreuzinger C; Tumorbank Ovarian Cancer Network, Berlin, Germany.
  • Gourley C; Division of Gynecological Oncology, Department of Gynaecology and Obstetrics, Leuven Cancer Institute, Universitaire Ziekenhuizen Leuven, Katholieke Universiteit Leuven, Leuven, Belgium.
  • Gabra H; Department of Gynecology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.
  • Taube ET; Tumorbank Ovarian Cancer Network, Berlin, Germany.
  • Dorigo O; Gynecology Division, Department of Medical and Surgical Sciences and Translational Medicine, Sant'Andrea University Hospital, Sapienza University of Rome, Rome, Italy.
  • Horst D; Department of Obstetrics and Gynecology, University Hospital LMU Munich, Munich, Germany.
  • Keunecke C; Department of Gynecology and Gynecological Oncology, University Hospital Bonn, Bonn, Germany.
  • Baum J; Department of Obstetrics and Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Angelotti T; Institute of Science and Technology Austria, Klosterneuburg, Austria.
  • Sehouli J; Nicola Murray Centre for Ovarian Cancer Research, University of Edinburgh Cancer Research UK Centre, MRC Institute of Genetics and Cancer, Western General Hospital, Edinburgh, UK.
  • Braicu EI; Ovarian Cancer Action Research Centre, Department of Surgery and Cancer, Imperial College London, London, UK.
Ann Surg Oncol ; 30(1): 46-47, 2023 Jan.
Article en En | MEDLINE | ID: mdl-36335272

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Alemania